Stanniocalcin 2 Expression: A Significant Marker in the Prognosis of Colorectal Carcinoma: Prognosis of Colorectal Carcinoma

Salman Zafar; Nazia Qamar; Madeeha Shahid; Shahid Kamran; Sadia Sundus; Zubia Aziz

doi:10.54393/pjhs.v5i10.2016

Authors

Salman Zafar Department of Pathology, Fazaia Ruth Pfau Medical College, Karachi, Pakistan
Nazia Qamar Department of Pathology, Fazaia Ruth Pfau Medical College, Karachi, Pakistan
Madeeha Shahid Department of Surgery, Fazaia Ruth Pfau Medical College, Karachi, Pakistan
Shahid Kamran Department of Forensic Medicine, Al-Tibri Medical College, Karachi, Pakistan
Sadia Sundus Department of Anatomy, Liaquat College of Medicine and Dentistry, Karachi, Pakistan
Zubia Aziz Department of Biochemistry, Liaquat College of Medicine and Dentistry, Karachi, Pakistan

DOI:

https://doi.org/10.54393/pjhs.v5i10.2016

Keywords:

Lymph Node Metastasis, Tumor Progression, Colorectal Cancer, Perineural Invasion

Abstract

Colorectal Cancer (CRC) is one of the most common cancers worldwide and causes significant morbidity and mortality. Biomarkers that predict tumor behavior and prognosis were essential. Stanniocalcin-2 (STC2) was a glycoprotein hormone involved in tumor progression but its association with clinicopathological parameters in colorectal cancer needs to be studied. Objective: To evaluate the correlation of Stanniocalcin-2 expression with clinicopathological features of colorectal cancer including tumor grade, invasion, lymph node metastasis, perineural invasion, and disease prognosis. Methods: This retrospective observational study was conducted at Life Care Molecular and Polymerase Chain Reaction Lab Services, Karachi in collaboration with Fazaia Ruth Pfau Medical College. 60 paraffin-embedded blocks from colorectal cancer patients diagnosed between January 2020 and December 2022 were included. 10 colonic biopsies negative for malignancy were taken as controls. Immunohistochemically analysis of Stanniocalcin-2 was compared with clinicopathological parameters including tumor grade, invasion, lymph node status, and perineural invasion. Statistical significance was calculated at a 95% confidence level and 5% margin of error. Results: Stanniocalcin-2 was significantly associated with higher tumor grade, invasion, lymph node metastasis, and perineural invasion (p<0.05). Strong stanniocalcin-2 expression was associated with poor disease prognosis and aggressive tumor behavior. Conclusions: Stanniocalcin-2 was a poor prognostic marker in colorectal carcinoma and was linked to aggressive tumor features. Stanniocalcin-2 can be a useful biomarker to predict disease progression and treatment strategy.

References

Morgan E, Arnold M, Gini A, Lorenzoni V, Cabasag CJ, Laversanne M et al. Global burden of colorectal cancer in 2020 and 2040: incidence and mortality estimates from GLOBOCAN. Gut. 2023 Feb; 72(2): 338-44. doi: 10.1136/gutjnl-2022-327736. DOI: https://doi.org/10.1136/gutjnl-2022-327736

Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: a Cancer Journal for Clinicians. 2021 May; 71(3): 209-49. doi: 10.3322/caac.21660. DOI: https://doi.org/10.3322/caac.21660

Li N, Lu B, Luo C, Cai J, Lu M, Zhang Y et al. Incidence, mortality, survival, risk factor and screening of colorectal cancer: A comparison among China, Europe, and northern America. Cancer Letters. 2021 Dec; 522: 255-68. doi: 10.1016/j.canlet.2021.09.034. DOI: https://doi.org/10.1016/j.canlet.2021.09.034

Watanabe T, Shiozawa M, Kimura Y, Hiroshima Y, Hashimoto I, Komori K et al. Clinical Significance of Stanniocalcin2 mRNA Expression in Patients with Colorectal Cancer. Anticancer Research. 2021 Apr; 41(4): 2117-22. doi: 10.21873/anticanres.14983. DOI: https://doi.org/10.21873/anticanres.14983

Galal RS, Darweesh MF, Elmahdi MH. Immunohistochemical Expression of Stanniocalcin 2 in Colorectal Cancer: A Retrospective Egyptian Study. Iranian Journal of Pathology. 2022; 17(1): 15. doi: 10.30699/ijp.2021.521799.2559. DOI: https://doi.org/10.30699/ijp.2021.521799.2559

Mathey MD, Pennella CL, Zubizarreta P. Colorectal carcinoma in children and adolescents. Arch Argent Pediatr. 2021 Oct; 119(5): e487-98. doi: 10.5546/aap.2021.eng.e487. DOI: https://doi.org/10.5546/aap.2021.eng.e487

Wang J, Sahengbieke S, Xu X, Zhang L, Xu X, Sun L et al. Gene Expression Analyses Identify a Relationship Between Stanniocalcin 2 and the Malignant Behavior of Colorectal Cancer. Onco-targets and Therapy. 2018 Oct: 7155-68. doi: 10.2147/OTT.S167780.

Hu L, Zha Y, Kong F, Pan Y. Prognostic Value of High Stanniocalcin 2 Expression in Solid Cancers: A Meta-Analysis. Medicine. 2019 Oct; 98(43): e17432. doi: 10.1097/MD.0000000000017432. DOI: https://doi.org/10.1097/MD.0000000000017432

Qie S and Sang N. Stanniocalcin 2 (STC2): a universal tumour biomarker and a potential therapeutical target. Journal of Experimental & Clinical Cancer Research. 2022 May; 41(1): 161. doi: 10.1186/s13046-022-02370-w. DOI: https://doi.org/10.1186/s13046-022-02370-w

Li S, Huang Q, Li D, Lv L, Li Y, Wu Z. The significance of Stanniocalcin 2 in Malignancies and mechanisms. Bioengineered. 2021 Jan; 12(1): 7276-85. doi: 10.1080/21655979.2021.1977551. DOI: https://doi.org/10.1080/21655979.2021.1977551

Zhang C, Chen S, Ma X, Yang Q, Su F, Shu X et al. Upregulation of STC2 in colorectal cancer and its clinicopathological significance. Onco Targets and therapy. 2019 Feb: 1249-58. doi: 10.2147/OTT.S191609. DOI: https://doi.org/10.2147/OTT.S191609

Li Q, Zhou X, Fang Z, Pan Z. Effect of STC2 gene silencing on colorectal cancer cells. Molecular Medicine Reports. 2019 Aug; 20(2): 977-84. doi: 10.3892/mmr.2019.10332. DOI: https://doi.org/10.3892/mmr.2019.10332

Mathur P, Sathishkumar K, Chaturvedi M, Das P, Sudarshan KL, Santhappan S et al. Cancer statistics, 2020: report from national cancer registry programme, India. JCO global oncology. 2020 Jul; 6: 1063-75. doi: 10.1200/GO.20.00122. DOI: https://doi.org/10.1200/GO.20.00122

Zhang ZH, Wu YG, Qin CK, Rong ZH, Su ZX, Xian GZ. Stanniocalcin 2 expression predicts poor prognosis of hepatocellular carcinoma. Oncology Letters. 2014 Nov; 8(5): 2160-4. doi: 10.3892/ol.2014.2520. DOI: https://doi.org/10.3892/ol.2014.2520

Wen Z, Luo D, Wang S, Rong R, Evers BM, Jia L, Fang Y et al. Deep Learning-Based H-Score Quantification of Immunohistochemistry-Stained Images. Modern Pathology. 2024 Feb; 37(2): 100398. doi: 10.1016/j.modpat.2023.100398. DOI: https://doi.org/10.1016/j.modpat.2023.100398

Joshi AD. New insights into physiological and pathophysiological functions of stanniocalcin 2. Frontiers in Endocrinology. 2020 Mar; 11: 172. doi: 10.3389/fendo.2020.00172. DOI: https://doi.org/10.3389/fendo.2020.00172

Das PK, Islam F, Lam AK. The roles of cancer stem cells and therapy resistance in colorectal carcinoma. Cells. 2020 Jun; 9(6):1392. doi: 10.3390/cells9061392. DOI: https://doi.org/10.3390/cells9061392

Mármol I, Sánchez-de-Diego C, Pradilla Dieste A, Cerrada E, Rodriguez Yoldi MJ. Colorectal carcinoma: a general overview and future perspectives in colorectal cancer. International Journal of Molecular Sciences. 2017 Jan;18(1):197. doi: 10.3390/ijms18010197. DOI: https://doi.org/10.3390/ijms18010197

Kim MS, Park EJ, Kang J, Min BS, Lee KY, Kim NK et al. Prognostic factors predicting survival in incurable stage IV colorectal cancer patients who underwent palliative primary tumor resection. Retrospective cohort study. International Journal of Surgery. 2018 Jan; 49: 10-5. doi: 10.1016/j.ijsu.2017.11.038. DOI: https://doi.org/10.1016/j.ijsu.2017.11.038

Wang J, Sahengbieke S, Xu X, Zhang L, Xu X, Sun L et al. Gene expression analyses identify a relationship between stanniocalcin 2 and the malignant behavior of colorectal cancer. OncoTargets and Therapy. 2018 Oct: 7155-68. doi: 10.2147/OTT.S167780 DOI: https://doi.org/10.2147/OTT.S167780